Therapeutic vaccination against HIV. (Q35851825)

10 August 2017

1 reference

title

Therapeutic vaccination against HIV. (English)

1 reference

10 August 2017

1

Britta Wahren

1 reference

10 August 2017

Margaret Liu

2

1 reference

10 August 2017

publication date

1 August 2004

1 reference

Expert Review of Vaccines

10 August 2017

published in

1 reference

10 August 2017

volume

3

1 reference

10 August 2017

issue

4 Suppl

1 reference

10 August 2017

page(s)

S179-88

1 reference

Skewed maturation of memory HIV-specific CD8 T lymphocytes

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

HIV immunotherapeutic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Challenges and opportunities for development of an AIDS vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

21 January 2018

HIV vaccines 1983-2003.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Vaccines against intracellular infections requiring cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Infection of baboons with a simian immunodeficiency virus/HIV-1 chimeric virus constructed with an HIV-1 Thai subtype E envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Vaccination with Rev and Tat against AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

An anti-HIV strategy combining chemotherapy and therapeutic vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Immune intervention strategies for HIV-1 infection of humans in the SIV macaque model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Gene combination raises broad human immunodeficiency virus-specific cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

HIV subtypes and recombination strains--strategies for induction of immune responses in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

HIV-specific immunity during structured antiviral drug treatment interruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Immune control of HIV-1 after early treatment of acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S179

10.1586/14760584.3.4.S179

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference